FDA Warning Letter — LAPOINT STORE

Case 556352 — FEI 3014470557

The FDA took a Warning Letter action against LAPOINT STORE on Jun 7, 2018 (LAPOINTE, UT). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
LAPOINT STORE
Date
Jun 7, 2018
Fiscal Year
2018
Product Type
Tobacco
Center
CTP
Location
LAPOINTE, UT (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.